NCT00849576

Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: Biodel · Industry
• Sex: All
• Age: 40 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the effects of insulin VIAject with Regular Human Insulin and Insulin Lispro on measures of mealtime blood vessel stress and blood flow.

Conditions

• Type 2 Diabetes

Interventions

Type	Name	Description
DRUG	Regular Human Insulin	0.10 U/Kg- 15 minutes before ingestion of a standardized liquid meal.
DRUG	Insulin Lispro	90% of Regular Human Insulin dose administer immediately before ingestion of a standardized liquid meal.
DRUG	Insulin VIAject™ (75%)	75 % of Regular Human Insulin dose administer immediately before ingestion of a standardized liquid meal
DRUG	Insulin VIAject™ (90%)	90 % of Regular Human Insulin dose administer immediately before ingestion of a standardized liquid meal

Timeline

• Start date: 2008-04-01
• Primary completion: 2008-08-01
• Completion: 2008-08-01
• First posted: 2009-02-24
• Last updated: 2015-08-03

Locations

1 site across 1 country: Germany